Reference:
Parry, P. I., Lefringhausen, A., Turni, C., Neil, C. J., Cosford, R., Hudson, N. J., & Gillespie, J. (2023). ‘Spikeopathy’: COVID-19 Spike Protein Is Pathogenic, from Both Virus and Vaccine mRNA. Biomedicines, 11(8), 2287. https://doi.org/10.3390/biomedicines11082287
Summary:
The article discusses the pathogenicity of the COVID-19 spike protein, termed ‘spikeopathy’, derived from both the virus and mRNA vaccines. It highlights concerns regarding the safety and efficacy of COVID-19 vaccines, particularly the adverse events linked to spike proteins produced by human cells post-vaccination. The review provides a comprehensive overview of the spike protein’s effects across various organ systems, including autoimmune, cardiovascular, and neurological implications. It emphasizes the need for greater scrutiny of gene-based vaccine technologies, given the evidence of widespread harm and the potential for long-term health consequences. The authors argue for a reevaluation of the risk-benefit analysis of these vaccines in light of the accumulating data indicating significant adverse effects, alongside the need for improved pharmacovigilance and regulatory oversight in future vaccine development.